Close

Production & Manufacturing

Biostar to manufacture, supply five additional drugs to Xijing Hospital

Biostar Pharmaceuticals has entered into an agreement worth $3m to manufacture and supply five additional drugs to Xijing Hospital for one-year. The five drugs include Qing Wen Granule, Ru Xiao Kang Capsule, Stomach and...

Pfizer joins forces with Mylan for generic drugs development

Pfizer and Mylan have entered into a collaboration agreement to develop, manufacture, distribute and market generic drugs in Japan. Under the agreement, Pfizer will take responsibilities for the commercialization of the combined generics portfolio,...

Alexza Adasuve manufacturing facility wins EU Certificate of GMP Compliance

Alexza Pharmaceuticals, a pharmaceutical company, has received EU Certificate of GMP Compliance for its Adasuve manufacturing facility. In May 2012, Alexza hosted an EU GMP inspection, which was conducted by the Agencia Espanola de...

Tris Pharma completes first phase of manufacturing expansion

Tris Pharma has initiated an expansion of its manufacturing capacity earlier in 2012 and is roughly midway through a 15 month expansion. The expansion will take the company's footprint from its current 90,000ft² to...

Merus Labs acquires Emselex/Enablex drug rights in Canada, Europe

Specialty pharmaceutical company, Merus Labs International, has acquired Emselex/Enablex (darifenacin) extended release tablets rights from Novartis Pharma in Canada and Europe, excluding France, Spain and Italy. As part of the acquisition, Merus Labs will...

Xcellerex launches new bag-type XDR-10 single-use bioreactor

Xcellerex, a provider of manufacturing technologies, has launched new XDR-10 single-use bioreactor. The new system, which is available in single-, twin-, triplet-, and quad-vessel configurations, is flexible to handle volumes from 4l to 10l....

Clarity Pharmaceuticals, Dalton Pharma sign manufacturing services contract

Dalton Pharma Services has entered into a Manufacturing Services contract with Clarity Pharmaceutical. Under the agreement Clarity's PET based companion diagnostics and radio-immunotherapeutics development program will receive cGMP chemistry manufacturing,scale up and aseptic fill/finish...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read